SOPHiA GENETICS (SOPH) Cash from Operations (2020 - 2025)

SOPHiA GENETICS has disclosed Cash from Operations across 6 years of filings, most recently posting 8141000.0 for Q4 2025.

• Cash from Operations for Q4 2025 came in at 8141000.0, up 22.64% year-over-year; the trailing twelve-month figure through Dec 2025 was 35693000.0 (up 18.84% YoY), and the FY2025 annual result was 35693000.0, up 18.84% from the prior year.
• Cash from Operations came in at 8141000.0 for Q4 2025 at SOPHiA GENETICS, up from 8734000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 8113000.0 in Q2 2025 to a low of 23088000.0 in Q3 2022.
• The 5-year median for Cash from Operations is 11784000.0 (2023), against an average of 13056300.0.
• Across the five-year window, Cash from Operations plunged 71.39% in 2022 and surged 44.04% in 2023, its largest moves.
• SOPHiA GENETICS's Cash from Operations stood at 15419000.0 in 2021, then increased by 28.85% to 10971000.0 in 2022, then declined by 14.4% to 12551000.0 in 2023, then rose by 16.15% to 10524000.0 in 2024, then rose by 22.64% to 8141000.0 in 2025.
• The last three Cash from Operations figures came in at 8141000.0 (Q4 2025), 8734000.0 (Q3 2025), and 8113000.0 (Q2 2025), per Business Quant data.